Delivery Order SPE2DR25D3009-SPE2DR26FWHC5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,371.36 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Heparin 10,000 Unit/10 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 29, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used in this award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $3,213 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 ML injectable medication, with completion scheduled for October 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Heparin 25,000 Unit/250 mL-D5W solution totaling $2,908.91 on December 26, 2025, with completion scheduled for December 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,023.55 delivery order to AmerisourceBergen Drug Corp for Heparin 25,000 unit/250-1/2 normal saline 250ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on October 31, 2025, with an ultimate completion date of November 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250 mL in dextrose 5% water solution, with a ceiling value of $1,060.15. This competitively awarded, non-set-aside delivery order is effective through December 24, 2025, and represents a firm fixed-price transaction. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and a distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 ML injectable medication. This competitively awarded, firm fixed-price contract carries a ceiling value of $6,523.37 and is scheduled for completion by December 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 mL injections with a ceiling value of $4,419.10. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250 mL in 5% Dextrose Water (D5W) solution, with a ceiling value of $1,061.90. This competitive, firm fixed-price delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,953.89, is for the delivery of 25,000 unit/250 ML heparin solutions in 250 ML bags. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order (SPE2DB22D3301|SPE2DB24FY7HB) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,285.84 firm fixed-price contract is for the supply of 4564702568 - HEPARIN 25,000 UNIT/250 ML-D5W 250ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWHC5Delivery Order
The Defense Logistics Agency awarded a $4,929.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Heparin 25,000 Unit/500 ML-D5W in 500 ML quantities. This non-competitive delivery order, with an ultimate completion date of January 7, 2026, represents a task order issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026). The work is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal military and veteran healthcare systems. This delivery order exemplifies the routine pharmaceutical procurement activities conducted under the DLA's comprehensive pharmaceutical prime vendor contract vehicle, which enables efficient fulfillment of medical supply needs across military treatment facilities and defense healthcare programs. The firm fixed-price delivery order structure and minimal timeline reflect the urgent nature of heparin procurement for ongoing military medical operations. No set-aside designation was applied to this award, consistent with AmerisourceBergen's demonstrated capability to compete on a full and open basis for federal pharmaceutical contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/5/26 |